← Back to Search

Family Involvement for PTSD

N/A
Recruiting
Led By Johanna Thompson-Hollands, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
- a current DSM-5 diagnosis of PTSD
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 26
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether a brief family intervention (BFI) can help reduce the rate of treatment dropout and improve symptoms in veterans with PTSD who are receiving cognitive processing therapy (CPT) or prolonged exposure (PE).

Who is the study for?
This trial is for Veterans with PTSD who are starting or have just started individual CPT or PE therapy, and are willing to involve a family member. The Veteran must be stable on any psychotropic meds for at least 30 days. Family members over 18 who see the Veteran frequently but don't have PTSD can join.
What is being tested?
The study tests if involving family in treatment through a Brief Family Intervention (BFI) helps Veterans with PTSD stick to their therapy better and improve symptoms more than usual care alone. It's a randomized test where some families get BFI while others don't.
What are the potential side effects?
Since the intervention involves psychoeducation and skills training rather than medication, typical medical side effects aren't expected. However, discussing traumatic events could potentially cause emotional discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with PTSD.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 26
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 26 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adequate treatment dose
Clinician-Administered PTSD Scale for DSM-5 (CAPS-5)
Treatment dropout
Secondary study objectives
Homework compliance
Quality of Life Inventory (QOLI)

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: BFIExperimental Treatment1 Intervention
Family members in this arm receive the 2-session BFI intervention.
Group II: No BFIActive Control1 Intervention
Family members in this arm do not receive the BFI sessions

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,666 Previous Clinical Trials
3,765,609 Total Patients Enrolled
Johanna Thompson-Hollands, PhDPrincipal InvestigatorVA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
1 Previous Clinical Trials
40 Total Patients Enrolled

Media Library

Brief Family Intervention (BFI) Clinical Trial Eligibility Overview. Trial Name: NCT05267665 — N/A
Post-Traumatic Stress Disorder Research Study Groups: BFI, No BFI
Post-Traumatic Stress Disorder Clinical Trial 2023: Brief Family Intervention (BFI) Highlights & Side Effects. Trial Name: NCT05267665 — N/A
Brief Family Intervention (BFI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05267665 — N/A
~64 spots leftby Mar 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top